(Q33965085)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12651195%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

review article

1 reference

title

Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12651195%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12651195%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

M J Duffy

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12651195%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A van Dalen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12651195%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

C Haglund

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12651195%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

L Hansson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12651195%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

R Klapdor

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12651195%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

R Lamerz

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12651195%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

O Nilsson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12651195%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

C Sturgeon

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12651195%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 April 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12651195%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12651195%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12651195%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12651195%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

718-727

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12651195%20AND%20SRC:MED&resulttype=core&format=json

The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

Estimates of the worldwide incidence of 25 major cancers in 1990.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

Colon cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

Prevention and treatment of colorectal cancer: pay now or pay later

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

Carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

Tumour markers of prognosis in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

The prognostic importance of tumor markers in adenocarcinomas of the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

Should carcinoembryonic antigen be used in the management of patients with colorectal cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

Preoperative carcinoembryonic antigen predicts outcomes in node-negative colon cancer patients: a multivariate analysis of 572 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

Surveillance after colorectal cancer resection

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

Role of follow-up in management of local recurrences of colorectal cancer: a prospective, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

Postsurgical surveillance of colon cancer: preliminary cost analysis of physician examination, carcinoembryonic antigen testing, chest x-ray, and colonoscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

Carcinoembryonic antigen (CEA) in diagnosis and prognosis of colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

Follow-up of colorectal cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

Follow-Up of Patients with Colorectal Cancer A Meta-Analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

Current treatment for colorectal cancer metastatic to the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

Hepatic toxicity associated with fluorouracil plus levamisole adjuvant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

Assessment of serial carcinoembryonic antigen: determinations to monitor the therapeutic progress and prognosis of metastatic liver disease treated by regional chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

Pre- and postoperative carcinoembryonic antigen determinations in hepatic resection for colorectal metastases. Predictive value and implications for adjuvant treatment based on multivariate analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

CA 19-9 as a marker for gastrointestinal cancers: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

The association of preoperative serum tumour markers with Dukes' stage and survival in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

CA19-9 as a predictor of recurrence in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

Prognostic significance of CEA and CA 19-9 in colorectal cancer in Kuwait

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

Use of CA 19-9 in the early detection of recurrences in colorectal cancer: comparison with CEA

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

CEA and CA 19-9 measurement as a monitoring parameter in metastatic colorectal cancer (CRC) under palliative first-line chemotherapy with weekly 24-hour infusion of high-dose 5-fluorouracil (5-FU) and folinic acid (FA).

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

Independent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotrophin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

Pre-operative serum levels of CA 242 and CEA predict outcome in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

The role of CA-242 and CEA in surveillance following curative resection for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

Sensitivity and specificity of CA242 in gastro-intestinal cancer. A comparison with CEA, CA50 and CA 19-9

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

Differences in serum tumor markers between colon and rectal cancer. Comparison of CA 242 and carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

Changing views of the role of matrix metalloproteinases in metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

A genetic model for colorectal tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

Detecting colorectal cancer in stool with the use of multiple genetic targets

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

Stool screening for colorectal cancer: evolution from occult blood to molecular markers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

Cellular oncogenes and suppressor genes as prognostic markers in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

The DCC protein and prognosis in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

Urokinase-type plasminogen activator and outcome in Dukes' B colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

Molecular markers predictive of response to chemotherapy in gastrointestinal tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

Molecular predictors of survival after adjuvant chemotherapy for colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900811-0

7 January 2021

10.1016/S0959-8049(02)00811-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12651195%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference